171 related articles for article (PubMed ID: 28943911)
1. Microplate magnetic chemiluminescence immunoassay for detecting urinary survivin in bladder cancer.
Chang Y; Xu J; Zhang Q
Oncol Lett; 2017 Oct; 14(4):4043-4052. PubMed ID: 28943911
[TBL] [Abstract][Full Text] [Related]
2. Detection of urinary survivin using a magnetic particles-based chemiluminescence immunoassay for the preliminary diagnosis of bladder cancer and renal cell carcinoma combined with LAPTM4B.
Yang Y; Xu J; Zhang Q
Oncol Lett; 2018 May; 15(5):7923-7933. PubMed ID: 29725479
[TBL] [Abstract][Full Text] [Related]
3. A rapid and sensitive chemiluminescence immunoassay based on magnetic particles for squamous cell carcinoma antigen in human serum.
Zhang H; Qi S
Clin Chim Acta; 2011 Aug; 412(17-18):1572-7. PubMed ID: 21600892
[TBL] [Abstract][Full Text] [Related]
4. Sandwich ELISA for detecting urinary Survivin in bladder cancer.
Li X; Wang Y; Xu J; Zhang Q
Chin J Cancer Res; 2013 Aug; 25(4):375-81. PubMed ID: 23997523
[TBL] [Abstract][Full Text] [Related]
5. Detection of survivin expression in bladder cancer and renal cell carcinoma using specific monoclonal antibodies.
Chen D; Xu J; Zhang Q
Oncol Rep; 2018 Jun; 39(6):2817-2828. PubMed ID: 29658613
[TBL] [Abstract][Full Text] [Related]
6. A magnetic particles-based chemiluminescence enzyme immunoassay for rapid detection of ovalbumin.
Feng XL; Ren HL; Li YS; Hu P; Zhou Y; Liu ZS; Yan DM; Hui Q; Liu D; Lin C; Liu NN; Liu YY; Lu SY
Anal Biochem; 2014 Aug; 459():12-7. PubMed ID: 24769049
[TBL] [Abstract][Full Text] [Related]
7. Development of high-performance magnetic chemiluminescence enzyme immunoassay for alpha-fetoprotein (AFP) in human serum.
Wang X; Zhang QY; Li ZJ; Ying XT; Lin JM
Clin Chim Acta; 2008 Jul; 393(2):90-4. PubMed ID: 18402780
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic accuracy of urinary survivin mRNA expression detected by RT-PCR compared with urine cytology in the detection of bladder cancer: A meta-analysis of diagnostic test accuracy in head-to-head studies.
Fu L; Zhang J; Li L; Yang Y; Yuan Y
Oncol Lett; 2020 Feb; 19(2):1165-1174. PubMed ID: 31966046
[TBL] [Abstract][Full Text] [Related]
9. Development of a rapid and high-performance chemiluminescence immunoassay based on magnetic particles for protein S100B in human serum.
Zhang H; Qi S; Rao J; Li Q; Yin L; Lu Y
Luminescence; 2013; 28(6):927-32. PubMed ID: 23319388
[TBL] [Abstract][Full Text] [Related]
10. Urine detection of survivin is a sensitive marker for the noninvasive diagnosis of bladder cancer.
Shariat SF; Casella R; Khoddami SM; Hernandez G; Sulser T; Gasser TC; Lerner SP
J Urol; 2004 Feb; 171(2 Pt 1):626-30. PubMed ID: 14713774
[TBL] [Abstract][Full Text] [Related]
11. Value of urinary survivin as a diagnostic marker in bladder cancer.
Abd El-Hakim TF; El-Shafie MK; Abdou AG; Azmy RM; El-Naidany SS; Badr El-Din MO
Anal Quant Cytopathol Histpathol; 2014 Jun; 36(3):121-7. PubMed ID: 25141488
[TBL] [Abstract][Full Text] [Related]
12. The diagnostic efficacy of urinary survivin and hyaluronidase mRNA as urine markers in patients with bladder cancer.
Eissa S; Badr S; Barakat M; Zaghloul AS; Mohanad M
Clin Lab; 2013; 59(7-8):893-900. PubMed ID: 24133921
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a New Survivin ELISA and UBC
Gleichenhagen J; Arndt C; Casjens S; Meinig C; Gerullis H; Raiko I; Brüning T; Ecke T; Johnen G
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29324722
[TBL] [Abstract][Full Text] [Related]
14. Determining the concentration of procalcitonin using a magnetic particles-based chemiluminescence assay for the clinical diagnosis of sepsis.
Qi S; Li Q; Rao W; Liu X; Yin L; Zhang H
Anal Sci; 2013; 29(8):805-10. PubMed ID: 23934561
[TBL] [Abstract][Full Text] [Related]
15. Development of a fully automated chemiluminescence immunoassay for urine monomeric laminin-γ2 as a promising diagnostic tool of non-muscle invasive bladder cancer.
Nakagawa M; Karashima T; Kamada M; Yoshida E; Yoshimura T; Nojima M; Inoue K; Shuin T; Seiki M; Koshikawa N
Biomark Res; 2017; 5():29. PubMed ID: 29046806
[TBL] [Abstract][Full Text] [Related]
16. Exploring solid-phase proximity ligation assay for survivin detection in urine.
Gleichenhagen J; Arndt C; Casjens S; Töpfer C; Gerullis H; Raiko I; Taeger D; Ecke T; Brüning T; Johnen G
PLoS One; 2022; 17(6):e0270535. PubMed ID: 35767525
[TBL] [Abstract][Full Text] [Related]
17. A quantitative detection of Cardiotrophin-1 in chronic heart failure by chemiluminescence immunoassay.
Ping Y; Wang X; Dai Y; Wang D; Liu W; Yu P; Tao Z
J Clin Lab Anal; 2021 Apr; 35(4):e23570. PubMed ID: 33713510
[TBL] [Abstract][Full Text] [Related]
18. Detection of urine survivin in 40 patients with bladder cancer.
Ohsawa I; Nishimura T; Kondo Y; Kimura G; Satoh M; Matsuzawa I; Hamasaki T; Ohta S
J Nippon Med Sch; 2004 Dec; 71(6):379-83. PubMed ID: 15673958
[TBL] [Abstract][Full Text] [Related]
19. Urine detection of survivin and diagnosis of bladder cancer.
Smith SD; Wheeler MA; Plescia J; Colberg JW; Weiss RM; Altieri DC
JAMA; 2001 Jan; 285(3):324-8. PubMed ID: 11176843
[TBL] [Abstract][Full Text] [Related]
20. Quantitative analysis of survivin mRNA expression in urine and tumor tissue of bladder cancer patients and its potential relevance for disease detection and prognosis.
Weikert S; Christoph F; Schrader M; Krause H; Miller K; Müller M
Int J Cancer; 2005 Aug; 116(1):100-4. PubMed ID: 15761870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
